Capital Flow Monitor · Sponsors · CIK 1898714

Bonum Therapeutics, Inc.

1150 EASTLAKE AVENUE E, SEATTLE, WA, 98109 · 206-888-8485

Biotechnology · Corporation· inc. DELAWARE true 2021

Fit score

—

Offering

$32.3M

Sold

$26.9M

% sold

83.3%

Investors

8

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-04-17 D ·current 506(b) $32.3M $26.9M 83.3% 8 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.